Author

Paolo Poggio

University of MilanORCID 0000-0002-7225-3379Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Vincenza ValerioiD· 3 shared Donato De Giorgi· 2 shared Donato MoschettaiD· 2 shared Francesca Bertolini· 2 shared Ilaria MassaiuiD· 2 shared Romain CapouladeiD· 2 shared Valentina Rusconi· 2 shared Veronika A. MyasoedovaiD· 2 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

Vincenza ValerioORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologyCardiovascular ResearchPeer-reviewedSep 5, 2026

Sirtuin 1 modulation unlocks the therapeutic potential of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in calcific aortic valve stenosis

Vincenza Valerio, Ilaria Massaiu, Matteo Franchi…·Paolo Poggio

This study shows SIRT1 regulates calcific aortic valve stenosis progression and that SGLT2i may slow valve degeneration by modulating SIRT1.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cell BiologybioRxivPreprintSep 26, 2024

Immortalization of human valve interstitial cells: an in vitro tool for studying fibro-calcific aortic valve degeneration

Donato Moschetta, Ilaria Massaiu, Francesca Bertolini…·Paolo Poggio

The paper immortalizes human valve interstitial cells to study fibro-calcific aortic valve degeneration and test drugs in vitro.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

GeneticsbioRxivPreprintMar 1, 2019

Genetic inhibition of PCSK9, atherogenic lipoprotein concentrations, and calcific aortic valve stenosis

Nicolas Perrot, Donato Moschetta, S. Matthijs Boekholdt…·Benoît J. Arsenault

This study shows genetic inhibition of PCSK9 lowers lipoprotein levels and reduces risk of CAD and CAVS, with PCSK9 present in calcified aortic valves and induced by oxidative stress.

DOI 10.1101/560458

humanstatistical model

𝕏 PostBluesky